Skip to content

Clinical trials

Trials in Norway with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Not applicable Country / region: Norway Clear all

2,078 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
20024
200314
200430
200550
200635
200735
200849
200969
201076
201177
201288
2013100
2014118
2015100
2016113
2017126
2018110
2019116
202098
2021138
2022115
2023112
2024109
2025110
202665

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,259
Unknown status248
Recruiting241
Active, not recruiting161
Terminated79
Not yet recruiting42
Enrolling by invitation27
Withdrawn18
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital317
Norwegian University of Science and Technology282
Haukeland University Hospital132
St. Olavs Hospital94
University of Oslo88
University of Bergen75
University Hospital of North Norway74
University Hospital, Akershus49
Oslo Metropolitan University47
Sorlandet Hospital HF41

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity86
Anxiety Disorders62
Pain56
Mental Disorders42
Cardiovascular Diseases41
Heart Failure38
Stroke36
Overweight35
Pulmonary Disease, Chronic Obstructive33
Coronary Artery Disease29

Trials

Showing 51 to 75 of 2,078. Each trial links to its page on Pharma Observatory.

1,978 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.